Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Capital Work in Progress

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹3,266 Cr₹2,739 Cr₹4,496 Cr₹2,938 Cr₹2,429 Cr

What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?

The latest Capital Work in Progress ratio of AUROBINDO PHARMA is ₹3,266 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹3,266 Cr
Mar2024₹2,739 Cr
Mar2023₹4,496 Cr
Mar2022₹2,938 Cr
Mar2021₹2,429 Cr

How is Capital Work in Progress of AUROBINDO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹3,266 Cr
19.22
Mar2024 ₹2,739 Cr
-39.08
Mar2023 ₹4,496 Cr
53.07
Mar2022 ₹2,938 Cr
20.94
Mar2021 ₹2,429 Cr -

Compare Capital Work in Progress of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹80,504.7 Cr 3.5% 5.5% 25.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

3.5%

5.5%

25.4%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses